Sign in

CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465270895
Phone
212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
  1. 8-K Event Executive or director change
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Exhibits
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 424B3 Offering Prospectus
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. S-3 Offering Registration Statement
  18. 8-K Event Other events
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 2 of 27 · 535 filings